» Articles » PMID: 21698055

The Association Among Lipoprotein-associated Phospholipase A2 Levels, Total Antioxidant Capacity and Arousal in Male Patients with OSA

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2011 Jun 24
PMID 21698055
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The mechanisms of the increased cardiac and vascular events in patients with OSA are not well understood. Arousal which is an important component of OSA was associated with increased sympathetic activation and electrocardiographic changes which prone to arrhythmias. We planned to examine the association among arousal, circulating Lp-PLA2 and total antioxidant capacity in male patients with OSA.

Methods: Fifty male patients with newly diagnosed OSA were enrolled the study. A full-night polysomnography was performed and arousal index was obtained. Lp-PLA2 concentrations were measured in serum samples with the PLAC Test. Total antioxidant capacity in patients was determined with Antioxidant Assay Kit.

Results: Arousal was positively correlated with LP-PLA2 levels (r=0.43, p=0.002) and was negatively correlated with total antioxidant capacity (r= -0.29, p=0.04). Elevated LP-PLA2 levels and decreased total antioxidant activities were found in the highest arousal quartile compared with the lowest and 2nd quartiles (p=0.02, p=0.05, respectively). LP-PLA2 was an independently predictor of arousal index in regression model (β=0.357, p=0.002)

Conclusions: This study demonstrated a moderate linear relationship between arousal and LP-PLA2 levels. Also, total antioxidant capacities were decreased in the higher arousal index. Based on the study result, the patients with higher arousal index may be prone to vascular events.

Citing Articles

SERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA.

Moise L, Marta D, Rascu A, Moldoveanu E Acta Endocrinol (Buchar). 2019; 14(1):36-42.

PMID: 31149234 PMC: 6516608. DOI: 10.4183/aeb.2018.36.


Vitamin D Improves Selected Metabolic Parameters but Not Neuropsychological or Quality of Life Indices in OSA: A Pilot Study.

Kerley C, Hutchinson K, Bramham J, McGowan A, Faul J, Cormican L J Clin Sleep Med. 2016; 13(1):19-26.

PMID: 27707440 PMC: 5181609. DOI: 10.5664/jcsm.6378.


Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.

Archontogeorgis K, Nena E, Papanas N, Steiropoulos P Pulm Med. 2014; 2014:930535.

PMID: 25538852 PMC: 4265695. DOI: 10.1155/2014/930535.


Influence of food patterns on endothelial biomarkers: a systematic review.

Defago M, Elorriaga N, Irazola V, Rubinstein A J Clin Hypertens (Greenwich). 2014; 16(12):907-13.

PMID: 25376124 PMC: 4270900. DOI: 10.1111/jch.12431.


Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.

Zamarron C, Valdes Cuadrado L, Alvarez-Sala R Pulm Med. 2013; 2013:521087.

PMID: 23936649 PMC: 3712227. DOI: 10.1155/2013/521087.

References
1.
Guilleminault C, Connolly S, Winkle R . Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983; 52(5):490-4. DOI: 10.1016/0002-9149(83)90013-9. View

2.
Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer B . Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology. 2005; 104(2):92-6. DOI: 10.1159/000086729. View

3.
Davies R, Belt P, Roberts S, Ali N, Stradling J . Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol (1985). 1993; 74(3):1123-30. DOI: 10.1152/jappl.1993.74.3.1123. View

4.
Peppard P, Young T, Palta M, Skatrud J . Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000; 342(19):1378-84. DOI: 10.1056/NEJM200005113421901. View

5.
Blann A, Seigneur M, Steiner M, Miller J, McCollum C . Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost. 1998; 79(6):1080-5. View